Earnings NewsHealthcareAvid Bioservices Q3 2022 Earnings PreviewMar. 07, 2022 5:35 PM ETAvid Bioservices, Inc. (CDMO)By: SA News Team Avid Bioservices (NASDAQ:CDMO) is scheduled to announce Q3 earnings results on Tuesday, March 8th, after market close. The consensus EPS Estimate is $0.05 and the consensus Revenue Estimate is $25.31M Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.